Sin embargo, dos estudios aleatorizados, doble ciego, que incluyeron 16.492 pacientes y 5.380 pacientes con DM2, el Saxagliptin Assessment of Vascular Outcomes Reported (SAVOR)70 y el Examitation of Cardiovascular Outcomes with Alogliptin versus standar of care (EXAMINE)71, reportaron tasas bajas de pancreatitis aguda similares a los grupos placebo (EXAMINE, 22 y 16 pacientes) y (SAVOR, 12 y 8 pacientes)
4 AFTER THE INJECTION Regular follow-up appointments to monitor progress and adjust dosage as needed
Free radicals cause "oxidative stress," which damages cell structures and accelerates aging
Commenting on the patient safety alert, Douglas Twenefour, head of care at Diabetes UK, said: The ongoing shortages of GLP-1 medications are having serious implications for many people with T2DM and are still a major concern
Effect of subcutaneous tirzepatide vs placebo added to titrated insulin glargine on glycemic control in patients with type 2 diabetes: the SURPASS-5 randomized clinical trial